RedHill Biopharma Terminates License Agreement for Aemcolo®
09 Jul 2024 //
PR NEWSWIRE
RedHill`s COVID-19 pill prevents hospitalization in small trial
02 Mar 2022 //
FIERCEBIOTECH
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of RHB-107
13 Sep 2021 //
PRNEWSWIRE
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
08 Sep 2020 //
PRESS RELEASE
RedHill Biopharma Announces Agreement with NIAID to Evaluate RHB-107
20 Apr 2020 //
REDHILLBIO